We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+10.48%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$187M
AUM Growth
-$27.2M
Cap. Flow
-$38M
Cap. Flow %
-20.28%
Top 10 Hldgs %
43.93%
Holding
89
New
25
Increased
12
Reduced
22
Closed
25

Top Buys

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$5.07M
2
GILD icon
Gilead Sciences
GILD
+$4.16M
3
DXCM icon
DexCom
DXCM
+$2.66M
4
ETRM
EnteroMedics Inc.
ETRM
+$2.43M
5
RCPT
RECEPTOS INC COM STK (DE)
RCPT
+$2.39M

Top Sells

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$4.51M
2
MRK icon
Merck
MRK
+$3.97M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$3.91M
4
STJ
St Jude Medical
STJ
+$3.64M
5
PBYI icon
Puma Biotechnology
PBYI
+$3.59M

Sector Composition

Rank Sector Weight
1 Healthcare 70.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
1
Biogen
BIIB
$30.9B
$14.1M 7.51%
42,500
+4,500
+12% +$1.48M
GILD icon
2
Gilead Sciences
GILD
$162B
$12.5M 6.68%
117,500
+42,500
+57% +$4.16M
AMGN icon
3
Amgen
AMGN
$221B
$11.4M 6.12%
81,500
-1,000
-1% -$131K
MDT icon
4
Medtronic
MDT
$109B
$8.52M 4.55%
137,500
-15,000
-10% -$954K
ABBV icon
5
AbbVie
ABBV
$436B
$7.22M 3.86%
125,000
+40,000
+47% +$2.22M
CELG
6
DELISTED
Celgene Corp
CELG
$7.11M 3.8%
75,000
-30,000
-29% -$2.71M
XLB icon
7
PUT
State Street Materials Select Sector SPDR ETF
XLB
$8.62B
$6.39M 3.41%
+200,000
New +$4.99M
SUPN icon
8
Supernus Pharmaceuticals
SUPN
$2.71B
$5.21M 2.79%
600,000
+225,000
+60% +$2.03M
ZBH icon
9
Zimmer Biomet
ZBH
$18.9B
$5.03M 2.69%
+51,500
New +$5.07M
MRK icon
10
Merck
MRK
$320B
$4.74M 2.53%
83,840
-70,740
-46% -$3.97M
TRNX
11
DELISTED
TORNIER N V SHARES (NLD)
TRNX
$4.18M 2.23%
175,000
+50,000
+40% +$1.12M
GWPH
12
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$4.04M 2.16%
50,000
+7,500
+18% +$664K
AERI
13
DELISTED
Aerie Pharmaceuticals
AERI
$3.93M 2.1%
190,000
+44,300
+30% +$873K
VTRS icon
14
Viatris
VTRS
$20.6B
$3.64M 1.94%
80,000
-25,000
-24% -$1.22M
REGN icon
15
PUT
Regeneron Pharmaceuticals
REGN
$80B
$3.6M 1.93%
+10,000
New +$3.35M
IONS icon
16
Ionis Pharmaceuticals
IONS
$9.03B
$3.3M 1.76%
85,000
-50,000
-37% -$1.77M
RARE icon
17
Ultragenyx Pharmaceutical
RARE
$2.46B
$3.25M 1.74%
57,500
+15,700
+38% +$790K
UTHR icon
18
CALL
United Therapeutics
UTHR
$22.2B
$3.22M 1.72%
+25,000
New +$2.58M
RCPT
19
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$3.11M 1.66%
+50,000
New +$2.39M
ESPR
20
DELISTED
Esperion Therapeutics
ESPR
$3.06M 1.63%
125,000
– –
SPNC
21
DELISTED
Spectranetics Corp
SPNC
$3.06M 1.63%
115,000
-10,000
-8% -$269K
PFE icon
22
CALL
Pfizer
PFE
$145B
$2.96M 1.58%
+105,400
New +$2.96M
ETRM
23
DELISTED
EnteroMedics Inc.
ETRM
$2.88M 1.54%
2,232
+1,661
+291% +$2.43M
SNY icon
24
CALL
Sanofi
SNY
$103B
$2.82M 1.51%
+50,000
New +$2.69M
HZNP
25
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$2.7M 1.44%
220,000
-35,000
-14% -$407K
1
2 3 4

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q3 2014 Portfolio in Review

As of Q3 2014, Iguana Healthcare Management held 89 positions worth $187M, down 13% from $214M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Iguana Healthcare Management withdrew a net $38M in Q3 2014, closing 25 positions and reducing 22 holdings. Its most notable exit was HCA Healthcare, an estimated $4.51M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 71% of assets, up from 67% a quarter earlier.

Against the trend, Iguana Healthcare Management opened a new position in Zimmer Biomet worth $5.03M.

  • Iguana Healthcare Management's largest Q3 2014 buy was Zimmer Biomet: 51,500 shares worth $5.03M.
  • Iguana Healthcare Management added most to Gilead Sciences in Q3 2014, an estimated $4.16M increase.
  • Iguana Healthcare Management's biggest Q3 2014 reduction was Merck, cutting an estimated $3.97M.
  • Iguana Healthcare Management fully exited HCA Healthcare in Q3 2014, selling an estimated $4.51M.
  • Iguana Healthcare Management's ten largest holdings make up 44% of its $187M portfolio in Q3 2014.
  • Iguana Healthcare Management opened 25 new positions and closed 25 in Q3 2014.
  • Iguana Healthcare Management's portfolio value fell 13% quarter-over-quarter to $187M.

Based on Iguana Healthcare Management's 13F filing for Q3 2014, filed 14 Nov 2014.